Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-10-13 Purchase |
2020-10-15 7:18 pm |
Aimmune Therapeutics Inc. | AIMT | Societe des Produits Nestle S.A. 10% Owner |
54,117,287 | $34.5 | $1,867,046,402 | 36,661,564 (Indirect Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer |
20,250 | $34.5 | $698,625 | 0 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks |
36,875 | $34.5 | $1,272,188 | 0 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | Dallas Jayson Donald Alexander President and CEO |
89,250 | $34.5 | $3,079,125 | 0 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director |
7,840 | $34.5 | $270,480 | 0 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | Behar Gregory Director |
7,840 | $34.5 | $270,480 | 10,192 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director |
13,313 | $34.5 | $459,299 | 0 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | Seltzer Stacey Denenberg Director |
7,840 | $34.5 | $270,480 | 0 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer |
23,905 | $34.5 | $824,723 | 0 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director |
7,840 | $34.5 | $270,480 | 0 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director |
7,840 | $34.5 | $270,480 | 0 (Indirect Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer |
22,343 | $34.5 | $770,834 | 0 (Direct) |
View |
| 2020-10-13 Sale |
2020-10-14 4:15 pm |
Aimmune Therapeutics Inc. | AIMT | FALBERG KATHRYN E Director |
7,840 | $34.5 | $270,480 | 0 (Indirect Direct) |
View |
| 2020-05-27 Sale |
2020-05-29 7:13 pm |
Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director |
7,840 | $0 | $0 | 6,206,933 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer |
6,345 | $34.5 | 0 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks |
47,450 | $34.5 | 0 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Dallas Jayson Donald Alexander President and CEO |
30,422 | $34.5 | 0 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director |
26,852 | $34.5 | 0 (Direct) |
View |
| 2020-10-13 Other |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Behar Gregory Director |
10,192 | $0 | 10,192 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director |
6,250 | $34.5 | 0 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Seltzer Stacey Denenberg Director |
10,221 | $34.5 | 0 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer |
27,805 | $34.5 | 0 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director |
39,567 | $34.5 | 0 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director |
162,258 | $34.5 | 0 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer |
41,464 | $34.5 | 0 (Direct) |
View |
| 2020-10-10 Equity Swap |
2020-10-14 4:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | FALBERG KATHRYN E Director |
135,086 | $34.5 | 0 (Direct) |
View |
| 2020-10-02 Exercise |
2020-10-05 9:20 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer |
34,932 | $11.45 | 198,875 (Direct) |
View |
| 2020-10-02 Exercise |
2020-10-05 9:20 pm |
N/A 2026-06-24 |
Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer |
34,932 | $0 | 198,875 (Direct) |
View |
| 2020-10-05 Exercise |
2020-10-05 9:14 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks |
30,888 | $12.95 | 107,787 (Direct) |
View |
| 2020-10-05 Exercise |
2020-10-05 9:14 pm |
N/A 2026-04-29 |
Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks |
30,888 | $0 | 107,787 (Direct) |
View |
| 2020-10-05 Exercise |
2020-10-05 9:13 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer |
5,200 | $19.44 | 314,641 (Direct) |
View |
| 2020-10-05 Exercise |
2020-10-05 9:13 pm |
N/A 2027-04-28 |
Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer |
5,200 | $0 | 314,641 (Direct) |
View |
| 2020-09-21 Other |
2020-09-23 9:35 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director |
6,204,831 | $0 | 6,374,929 (Indirect) |
View |
| 2020-09-15 Tax Withholding |
2020-09-16 5:20 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks |
840 | $34.25 | 54,538 (Direct) |
View |
| 2020-09-15 Tax Withholding |
2020-09-16 5:19 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer |
840 | $34.25 | 26,595 (Direct) |
View |
| 2020-09-15 Tax Withholding |
2020-09-16 5:18 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer |
840 | $34.25 | 44,547 (Direct) |
View |
| 2020-09-15 Tax Withholding |
2020-09-16 5:17 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Dallas Jayson Donald Alexander President and CEO |
1,642 | $34.25 | 117,034 (Direct) |
View |
| 2020-09-15 Tax Withholding |
2020-09-16 5:17 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer |
840 | $34.25 | 28,875 (Direct) |
View |
| 2020-06-22 Tax Withholding |
2020-06-26 5:06 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Dallas Jayson Donald Alexander President and CEO |
7,907 | $18.02 | 118,676 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:17 pm |
N/A 2030-05-26 |
Aimmune Therapeutics Inc. | AIMT | Iwicki Mark T Director |
23,238 | $0 | 62,805 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:17 pm |
N/A 2030-05-26 |
Aimmune Therapeutics Inc. | AIMT | Behar Gregory Director |
23,238 | $0 | 33,430 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:17 pm |
N/A 2030-05-26 |
Aimmune Therapeutics Inc. | AIMT | HAUMANN BRETT K Director |
38,766 | $0 | 45,016 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:15 pm |
N/A 2030-05-26 |
Aimmune Therapeutics Inc. | AIMT | FALBERG KATHRYN E Director |
23,238 | $0 | 158,324 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:13 pm |
N/A 2030-05-26 |
Aimmune Therapeutics Inc. | AIMT | ENRIGHT PATRICK G Director |
15,398 | $0 | 6,206,933 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:13 pm |
N/A 2030-05-26 |
Aimmune Therapeutics Inc. | AIMT | MCDADE MARK Director |
23,238 | $0 | 50,090 (Direct) |
View |
| 2020-05-27 Option Award |
2020-05-29 7:12 pm |
N/A 2030-05-26 |
Aimmune Therapeutics Inc. | AIMT | Seltzer Stacey Denenberg Director |
23,238 | $0 | 33,459 (Direct) |
View |
| 2020-05-10 Option Award |
2020-05-12 5:25 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Dallas Jayson Donald Alexander President and CEO |
3,300 | $0 | 126,583 (Direct) |
View |
| 2020-05-10 Option Award |
2020-05-12 5:24 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | BJERKHOLT ERIC Chief Financial Officer |
2,420 | $0 | 45,387 (Direct) |
View |
| 2020-05-10 Option Award |
2020-05-12 5:23 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Sheehy Douglas T. See Remarks |
2,420 | $0 | 55,378 (Direct) |
View |
| 2020-05-10 Option Award |
2020-05-12 5:20 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | Oxtoby Andrew Chief Commercial Officer |
2,420 | $0 | 27,435 (Direct) |
View |
| 2020-05-10 Option Award |
2020-05-12 5:15 pm |
N/A N/A |
Aimmune Therapeutics Inc. | AIMT | ADELMAN DANIEL C MD Chief Medical Officer |
2,420 | $0 | 29,715 (Direct) |
View |